Phase 3 clinical trials are the most expensive part of drug development, and the most important hurdle to regulatory approval. More than 95% of phase 3 trials in Alzheimer’s disease fail. The main reason is a poor foundation, namely, inadequate or misleading phase 2 trials. Dr. Donald Berry, Founder of Berry Consultants and Founder and Professor of the Department of Biostatistics at the University of Texas MD Anderson Cancer Center, along with his son Dr. Scott Berry, President of Berry Consultants, are committed to turning the tide. Their revolutionary methodology involves adaptive clinical trial design within a Bayesian statistical approach.

Childbirth is a remarkable event that brings joy and new beginnings but also poses significant physical challenges to the mother’s body. One such challenge is the separation of the pubic symphysis, a joint located between the left and right pubic bones. Dr. Kamalini Das of Regions Hospital, Minnesota, and her colleagues conducted a groundbreaking study to investigate pubic symphysis separation in women who delivered vaginally versus those who had cesarean sections. Their research provides important insights into the nature of this physiological change and its development postpartum.